Eutylone
β-Keto-1,3-benzodioxolyl-N-ethylbutanamine (Eutylone, bk-EBDB, N-Ethylbutylone) is a stimulant compound developed in the 1960s,[1] which has been reported as a novel designer drug.[2]
Clinical data | |
---|---|
ATC code |
|
Legal status | |
Legal status |
|
Identifiers | |
IUPAC name
| |
CAS Number |
|
PubChem CID | |
ChemSpider |
|
UNII | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C13H17NO3 |
Molar mass | 235.278 g/mol g·mol−1 |
3D model (JSmol) | |
SMILES
| |
InChI
| |
|
Legal status
Sweden's public health agency suggested classifying Eutylone as a hazardous substance, on September 25, 2019.[3]
References
- Substituted phenyl-α-amino ketones. British Patent GB 1085135 (1969).
- "Eutylone". New Synthetic Drugs Database.
- "Tretton ämnen föreslås klassas som narkotika eller hälsofarlig vara" (in Swedish). Folkhälsomyndigheten. 25 September 2019.
Empathogens/entactogens | |
---|---|
Phenylalkyl- amines (other than cathinones) |
|
Cyclized phenyl- alkylamines | |
Cathinones |
|
Tryptamines | |
Chemical classes |
This article is issued from
Wikipedia.
The text is licensed under Creative
Commons - Attribution - Sharealike.
Additional terms may apply for the media files.